← TrendWatcher
Google Trends
6/10

Quiet Symptoms

A symptom journal and risk-awareness companion built around the cancers that are hardest to catch early — pancreatic, ovarian, oesophageal — helping users log vague signs, prepare for the GP visit, and find screening trials.

Target user

Adults with a family history of pancreatic or other 'silent' cancers, plus anyone Googling symptoms after celebrity diagnoses

Features
  • Guided daily symptom log tuned to early-warning signs of silent cancers (jaundice, back pain, new-onset diabetes, weight loss)
  • GP-visit summary that turns your logs into a clear timeline and suggested questions
  • Clinical-trial matcher surfacing open pancreatic and GI oncology studies near you
  • Family-history intake that re-scores your baseline risk over time
Why now

The Affleck news spike drives 'pancreatic cancer' searches to 2000+ — surfacing a real gap between headline awareness and tools that help worried people act on symptoms they may have dismissed.

Signals · overall 6/10
Demand
7/10

Multiple peer-reviewed studies (MDPI/NIH) confirm celebrity pancreatic cancer diagnoses cause large, measurable spikes in related Google searches, and existing trackers like Wave Health and Cancer Tracker show real symptom-logging demand — but the spikes are transient and tied to news cycles rather than steady baseline interest.Using Google Trends and Wikipedia to Investigate the Global Public's Interest in the Pancreatic Cancer Diagnosis of a CelebrityWave Health: Symptom Tracker - Apps on Google Play

Whitespace
6/10

App stores are saturated with post-diagnosis trackers (Cancer Tracker, Proverse, Wave), but none specifically target the worried-well with vague symptoms of silent cancers or pair journaling with GP-visit prep + trial matching; PanCAN's Clinical Trial Finder is clinician-facing, leaving a real pre-diagnosis niche.Cancer Tracker - Apps on Google PlayPancreatic Cancer Clinical Trials

Monetization
4/10

Comparable cancer apps monetize via subscriptions, but PanCAN gives trial search away free and AI trial matching (ClinTrialFinder) is offered at no cost; an anxious, transient, news-driven audience is hard to convert to recurring paid tiers, suggesting modest direct monetization.ClinTrialFinder - AI-Powered Clinical Trial MatchingPancreatic Cancer Clinical Trials

Longevity
7/10

Silent cancers (pancreatic, ovarian, oesophageal) remain genuinely hard to detect early and will stay a persistent health concern regardless of news spikes, giving the idea long-term utility if positioned beyond celebrity-driven traffic.Celebrities With Pancreatic Cancer and Their Stories: Awareness Courage and Lessons for Survivors

Feasibility
5/10

Core components (symptom logging, GP-visit prep, trial feeds) are all buildable with off-the-shelf clinical trial data, but medical-advice liability, regulatory classification (could be considered a medical device), and the need for clinical credibility add non-trivial cost and risk.A mobile health app for real-time symptom monitoring in cancer patients - Springer

pancreatic cancer · 2000+ searches · USGoogle Trends · 2026-07-25 (today)